China closes Tibet's Potala Palace over COVID outbreak, and Novavax stock is slammed by weak earnings and halving of sales guidanceMarket Watch • 08/09/22
Novavax slumps after halving its sales forecast amid global supply glut and low vaccine demandProactive Investors • 08/09/22
Novavax, Inc.'s (NVAX) CEO Stan Erck on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22
Novavax Plummets: Covid Vaccine Sales Widely Lag On Unexpected Losses, Slashed GuidanceInvestors Business Daily • 08/08/22
Novavax Reports Second Quarter 2022 Financial Results and Operational HighlightsPRNewsWire • 08/08/22
Is Novavax's latest wins about to help it shed the meme tag when it reports earnings?Invezz • 08/05/22
Official U.S. new case tally may be declining but at-home testing obscures data, and Novavax starts trial of vaccine for very young childrenMarket Watch • 08/05/22
Novavax Announces Initiation of Phase 2b/3 Hummingbird™ Global Clinical Trial for the Novavax COVID-19 Vaccine in Children Aged Six Months Through 11 YearsPRNewsWire • 08/04/22
Novavax to Host Conference Call to Discuss Second Quarter 2022 Financial Results and Operational Highlights on August 8, 2022PRNewsWire • 08/01/22